High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy

Bone Marrow Transplantation

Volumn 41, Issue 4, 2008, Pages 393-398

  Yao, S ^a   McCarthy, P L ^a   Dunford, L M ^a   Roy, D M ^a   Brown, K ^a   Paplham, P ^a   Syta, M ^a   Lamonica, D ^a   Smiley, S ^a   Battiwalla, M ^a   Padmanabhan, S ^a   Hahn, T ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BUSULFAN; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE; GLUCOCORTICOID; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE DENSITY; BONE MINERAL; BONE NECROSIS; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; HEMATOLOGIC MALIGNANCY; HUMAN; JAW DISEASE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 40249094784     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705918     Document Type: Article

References (47)

1. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994; 4: 368-381.
2. Faulkner KG. Bone matters: Are density increases necessary to reduce fracture risk? J Bone Miner Res 2000; 15: 183-187.
3. King AB, Saag KG, Burge RT, Pisu M, Goel N. Fracture reduction affects medicare economics (FRAME): Impact of increased osteoporosis diagnosis and treatment. Osteoporos Int 2005; 16: 1545-1557.
4. Fogelman I, Blake GM. Bone densitometry: An update. Lancet 2005; 366: 2068-2070.
5. US Department of Health and Human Services OotSG. Bone Health and Osteoporosis: A Report of the Surgeon General. US Department of Health and Human Service, Office of the Surgeon General: Rockville, MD, USA, 2004.
6. Rodino MA, Shane E. Osteoporosis after organ transplantation. Am J Med 1998; 104: 459-469.
7. Kelly PJ, Atkinson K, Ward RL, Sambrook PN, Biggs JC, Eisman JA. Reduced bone mineral density in men and women with allogeneic bone marrow transplantation. Transplantation 1990; 50: 881-883.
8. Stern JM, Chesnut III CH, Bruemmer B, Sullivan KM, Lenssen PS, Aker SN et al. Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant 1996; 17: 395-400.
9. Castaneda S, Carmona L, Carvajal I, Arranz R, Diaz A, Garcia-Vadillo A. Reduction of bone mass in women after bone marrow transplantation. Calcif Tissue Int 1997; 60: 343-347.
10. Keilholz U, Max R, Scheibenbogen C, Wuster C, Korbling M, Haas R. Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation. Cancer 1997; 79: 1617-1622.
11. Bhatia S, Ramsay NK, Weisdorf D, Griffiths H, Robison LL. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant 1998; 22: 87-90.
12. Ebeling PR, Thomas DM, Erbas B, Hopper JL, Szer J, Grigg AP. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res 1999; 14: 342-350.
13. Kauppila M, Irjala K, Koskinen P, Pulkki K, Sonninen P, Viikari J et al. Bone mineral density after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 24: 885-889.
14. Valimaki MJ, Kinnunen K, Volin L, Tahtela R, Loyttyniemi E, Laitinnen K et al. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: Effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant 1999; 23: 355-361.
15. Kashyap A, Kandeel F, Yamauchi D, Palmer JM, Niland JC, Molina A et al. Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study. Biol Blood Marrow Transplant 2000; 6: 344-351.
16. Kang MI, Lee WY, Oh KW, Han JH, Song KH, Cha BY et al. The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone 2000; 26: 275-279.
17. Schulte C, Beelen DW, Schaefer UW, Mann K. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: A prospective study. Osteoporos Int 2000; 11: 344-353.
18. Nysom K, Holm K, Michaelsen KF, Hertz H, Jacobsen N, Muller J et al Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant 2000; 25: 191-196.
19. Banfi A, Podesta M, Fazzuoli L, Sertoli MR, Venturini M, Santini G et al. High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: A mechanism for post-bone marrow transplantation osteopenia. Cancer 2001; 92: 2419-2428.
20. Massenkeil G, Fiene C, Rosen O, Michael R, Reisinger W, Arnold R. Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: Standard prophylactic measures fail to prevent osteoporosis. Leukemia 2001; 15: 1701-1705.
21. Buchs N, Helg C, Collao C, Chapuis B, Slosman D, Bonjour JP et al. Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss. Osteoporos Int 2001; 12: 880-886.
22. Stern JM, Sullivan KM, Ott SM, Seidel K, Fink JC, Longton G et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study. Biol Blood Marrow Transplant 2001; 7: 257-264.
23. Schimmer AD, Mah K, Bordeleau L, Cheung A, Ali V, Falconer M et al Decreased bone mineral density is common after autologous blood or marrow transplantation. Bone Marrow Transplant 2001; 28: 387-391.
24. Lee WY, Cho SW, Oh ES, Oh KW, Lee JM, Yoon KH et al. The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab 2002; 87: 329-335.
25. Lee WY, Kang MI, Baek KH, Oh ES, Oh KW, Lee KW et al. The skeletal site-differential changes in bone mineral density following bone marrow transplantation: 3-year prospective study. J Korean Med Sci 2002; 17: 749-754.
26. Tauchmanova L, Serio B, Del Puente A, Risitano AM, Esposito A, De Rosa G et al. Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation. J Clin Endocrinol Metab 2002; 87: 5058-5065.
27. Gandhi MK, Lekamwasam S, Inman I, Kaptoge S, Sizer L, Love S et al Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: Long-term follow-up of a prospective study. Br J Haematol 2003; 121: 462-468.
28. Baek KIL Lee WY, Oh KW, Kim HS, Han JH, Kang MI et al. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: Impact on bone and mineral metabolism. J Clin Endocrinol Metab 2004; 89: 1246-1254.
29. Lee WY, Back KH, Rhee EJ, Tac HJ, Oh KW, Kang MI et al. Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation. Bone Marrow Transplant 2004; 34: 89-94.
30. Schulte CM, Beelen DW. Bone loss following hematopoietic stem cell transplantation: A long-term follow-up. Blood 2004; 103 3635-3643.
31. Kaste SC, Shidler TJ, Tong X, Srivastava DK, Rochester R, Hudson MM et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant 2004; 33: 435-441.
32. Petryk A, Bergemann TL, Polga KM, Ulrich KJ, Raatz SK, Brown DM et al Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation. J Clin Endocrinol Metab 2006; 91: 899-905.
33. Schulte CM, Beelen DW. Low pretransplant bone-mineral density and rapid bone loss do not increase risk for avascular osteonecrosis after allogeneic hematopoietic stem cell transplantation. Transplantation 2005; 79: 1748-1755.
34. Kerschan-Schindl K, Mitterbauer M, Fureder W, Kudlacek S, Grampp S, Bieglmayer C et al. Bone metabolism in patients more than five years after bone marrow transplantation. Bone Marrow Transplant 2004; 34: 491-496.
35. Kananen K, Volin L, Tahtela R, Laitinen K, Ruutu T, Valimaki MJ. Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 2002; 29: 33-39.
36. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
37. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
38. Baim S, Wilson CR, Lewiecki EM, Luckey MM, Downs Jr RW, Lentle BC. Precision assessment and radiation safety for dual-energy X-ray absorptiometry: Position paper of the International Society for Clinical Densitometry. J Clin Densitom 2005; 8: 371-378.
39. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457-481.
40. The NCCN GUIDELINE Breast Cancer, Clinical Practice Guidelines in Oncology (Version 2.2007). © 2007 National Comprehensive Cancer Network, Inc. [Available at: http://www.nccn.org. Accessed October 24, 2007].
41. Kananen K, Volin L, Laitinen K, Alfthan H, Ruutu T, Valimaki MI. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab 2005; 90: 3877-3885.
42. Dannemann C, Gratz KW, Riener MO, Zwahlen RA. Jaw osteonecrosis related to bisphosphonate therapy, a severe secondary disorder. Bone 2007; 40: 828-834.
43. Treister N, Woo SB. Images in clincial medicine. Bisphosphonate-associated osteonecrosis of the jaw. N Engl J Med 2006; 355: 2348.
44. Waclawski ER. Osteonecrosis of the jaw and bisphosphonates: Historical lesson from occupational medicine. BMJ 2006; 333: 1123.
45. Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int 2003; 14: 617-630.
46. Maalouf NM, Shane E. Osteoporosis after solid organ transplantation. J Clin Endocrinol Metab 2005; 90: 2456-2465.
47. Schimmer AD, Minden MD, Keating A. Osteoporosis after blood and marrow transplantation: Clinical aspects. Biol Blood Marrow Transplant 2000; 6: 175-181.